Statistics

Total Visits

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study43

Select a period of time:

Number of views in the range

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study8

Views

Views
May 20250
June 20250
July 20258
August 20250
September 20250
October 20250
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil4
United States2
Colombia1
Jamaica1
 

Top cities views

Views
Barranquilla1
East Hampton1
Guarulhos1
Montego Bay1
Piracicaba1
Rio de Janeiro1
São Paulo1